Integer Holdings Corporation to Exhibit Innovative Medical Device Solutions at MD&M West 2025

Integer Holdings Corporation will exhibit at MD&M West 2025, showcasing innovations in medical device manufacturing and rapid prototyping services.

Quiver AI Summary

Integer Holdings Corporation, a prominent medical device contract development and manufacturing organization, will showcase its innovative technologies and services at the MD&M West event from February 4 to 6, 2025, in Anaheim, California, at booth #1439. The company aims to highlight its expertise in enhancing patient lives through a range of solutions in cardio and vascular, cardiac rhythm management, and neuromodulation products, as well as its rapid prototyping services for specialized cardiovascular applications. Integer is also focusing on its recent acquisition of Precision Coating, which adds proprietary coating capabilities to its portfolio, thereby enhancing its service offerings. Attendees will have the opportunity to learn about Integer’s commitment to quality and innovation as a strategic partner in the evolving medical device landscape.

Potential Positives

• Integer Holdings Corporation will showcase its innovative medical device capabilities at MD&M West 2025, enhancing its visibility and engagement with industry leaders and potential customers.
• The acquisition of Precision Coating expands Integer’s service offerings to include specialized coatings, positioning the company to better meet evolving customer needs in the medical device industry.
• Integer's rapid prototyping services, with quick turnaround times, demonstrate its commitment to accelerating product development for customers within specialized markets.
• The announcement reflects Integer's ongoing strategic investments and a commitment to innovation, reinforcing its position as a trusted partner in the medical device landscape.

Potential Negatives

• The press release highlights an acquisition of Precision Coating for $152 million, which could raise concerns about financial strain or overextension if the integration doesn’t yield expected benefits.
• The emphasis on rapid prototyping and the need for a two-week turnaround may imply a competitive pressure to deliver quickly, potentially leading to quality control issues if not managed properly.
• Integer's focus on a "local-to-local" approach raises questions about scalability and the ability to handle larger or global projects efficiently.

FAQ

What is Integer Holdings Corporation showcasing at MD&M West 2025?

Integer will showcase innovative medical device solutions in cardio, vascular, cardiac rhythm management, and neuromodulation at MD&M West 2025.

Where is Integer's booth located at MD&M West 2025?

Integer's booth is located at booth #1439 at the Anaheim Convention Center.

What are the benefits of Integer's rapid prototyping services?

Integer's rapid prototyping services offer as little as a two-week turnaround for specialized cardiovascular products, enhancing innovation speed.

What recent acquisition did Integer Holdings make?

Integer acquired Precision Coating for $152 million, enhancing its coatings capabilities for medical device manufacturing.

When will Integer provide more details about its recent acquisition?

Integer will share additional details during itsearnings callon February 20, 2025.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$ITGR Hedge Fund Activity

We have seen 151 institutional investors add shares of $ITGR stock to their portfolio, and 147 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL RESEARCH GLOBAL INVESTORS added 949,134 shares (+355.8%) to their portfolio in Q3 2024, for an estimated $123,387,420
• SILVERCREST ASSET MANAGEMENT GROUP LLC removed 834,405 shares (-50.6%) from their portfolio in Q3 2024, for an estimated $108,472,650
• AMERICAN CENTURY COMPANIES INC added 415,604 shares (+2645.5%) to their portfolio in Q3 2024, for an estimated $54,028,520
• FULLER & THALER ASSET MANAGEMENT, INC. removed 310,110 shares (-24.0%) from their portfolio in Q3 2024, for an estimated $40,314,300
• FRANKLIN RESOURCES INC removed 298,752 shares (-31.3%) from their portfolio in Q3 2024, for an estimated $38,837,760
• ORBIMED ADVISORS LLC added 225,779 shares (+64.7%) to their portfolio in Q3 2024, for an estimated $29,351,270
• AMERIPRISE FINANCIAL INC added 216,311 shares (+24.8%) to their portfolio in Q3 2024, for an estimated $28,120,430

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Full Release

PLANO, Texas, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), will join innovators and industry leaders around the world in exhibiting at MD&M West, Feb. 4 – 6, 2025, at the Anaheim Convention Center in Anaheim, California.

Integer welcomes visitors to booth #1439 to learn more about the company’s commitment to customers as their partner of choice in enhancing the lives of patients through access to innovative technologies, superior quality and dependable manufacturing to accelerate speed to market and reduce product development risk.

Integer’s exhibit will showcase capabilities and solutions to enable cardio and vascular, cardiac rhythm management and neuromodulation products, and how the company blends technology, expertise and resources to amplify customers’ innovation.

Integer will additionally highlight its global rapid prototyping services that enable customers’ direct access to a team of dedicated experts in R&D and engineering. With a local-to-local approach and as little as a two-week turnaround, customers now can obtain rapid prototypes in specialized cardiovascular markets, including structural heart, electrophysiology and neurovascular. Offerings include catheter shafts and guidewires, steerable sheaths, introducers, braiding and textiles, and machined components.

“As we expand our capabilities and capacity through ongoing strategic investments, we will continue to anticipate our customers’ needs in a highly innovative and rapidly evolving medical device landscape,” said Payman Khales, President, Cardio and Vascular. “We look forward to demonstrating our collaborative approach, continued commitment to innovation, and the strategic value we provide as our customers’ trusted and reliable end-to-end partner in medical device technologies.”

Integer will also showcase a range of key product areas throughout the event, including:

• 
  Cardiac rhythm management and neuromodulation: Miniaturized technology for finished IPGs as well as Gen 3 Li Ion and Gen 2 CFx batteries.
  


• 
  Cardio and vascular solutions: A full range of electrophysiology, structural heart, and neurovascular product solutions including complex catheters, high-performing guidewires, steerable introducers and sheaths, therapy delivery systems, and implant technologies.
  

In addition to Integer’s exhibit at booth #1439, MD&M West 2025 attendees can visit Pulse Technologies, an Integer Company, at booth #2854 to learn more about HSR technology and complex micro machining for critical medical device components.

Attendees are also invited to visit Precision Coating at booth #2269. Integer acquired substantially all of the assets of Precision Coating, a privately held manufacturer specializing in high value surface coating technology platforms, including fluoropolymer, anodic coatings, ion treatment solutions and laser processing, on Jan. 7, 2025, for $152 million, subject to adjustment for additional contingent consideration. Consistent with Integer’s tuck-in acquisition strategy, the acquisition of Precision Coating increases Integer’s service offerings to include differentiated and proprietary coatings capabilities that position Integer to better meet customers’ evolving needs.

Integer will share additional details on this acquisition during its fourth quarter and full year 2024earnings callon Feb. 20, 2025.

Learn more about Integer at

www.integer.net

.

About Integer




^®





Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, the Company is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The Company's brands include Greatbatch Medical

^®

and Lake Region Medical

^®

. Additional information is available at

www.integer.net

.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.